Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Philip E. Sabato, PharmD, MS
Venatorx Pharmaceuticals
Disclosure(s): Venatorx Pharmaceuticals: Employee, Stocks/Bonds
Poster(s):
590 - Activities of Cefepime-Taniborbactam and Ceftazidime-Avibactam against Cefepime-Resistant Respiratory Gram-Negative Pathogens in a Hollow Fiber Infection Model
Thursday, October 20, 2022
12:15 PM – 1:30 PM
US ET
.png)
.png)